Belon Philippe, Banerjee Antara, Karmakar Susanta Roy, Biswas Surjyo Jyoti, Choudhury Sandipan Chaki, Banerjee Pathikrit, Das Jayanta Kumar, Pathak Surajit, Guha Bibhas, Paul Saili, Bhattacharjee Nandini, Khuda-Bukhsh Anisur Rahman
Boiron Lab, 20 rue de la Libèration, Sainte-Foy-Lés-Lyon, France.
Sci Total Environ. 2007 Oct 1;384(1-3):141-50. doi: 10.1016/j.scitotenv.2007.06.001. Epub 2007 Jul 12.
Millions of people are at risk of groundwater arsenic contamination, but supply of arsenic-free drinking water is grossly inadequate. The present study was intended to examine if a potentized homeopathic remedy reportedly showing ameliorating potentials in people inhabiting high-risk arsenic-contaminated areas but drinking arsenic-free water, can also ameliorate arsenic toxicity in subjects living in high-risk arsenic-contaminated areas, and drinking arsenic-contaminated water. This pilot study was conducted on 20 males and 19 females of village Dasdiya (arsenic contaminated) who initially agreed to act as volunteers; but as many as 14, mostly placebo-fed subjects, later dropped out. 18 volunteers, 14 males and 4 females, from a distant village, Padumbasan (arsenic-free), served as negative controls. In a double blind placebo-controlled study, a potentized remedy of homeopathic Arsenicum Album-30 and its placebo (Succussed Alcohol-30) were given randomly to volunteers. Arsenic contents in urine and blood and several widely accepted toxicity biomarkers and pathological parameters in blood were analyzed before and after 2 months of administration of either verum or placebo. Elevated levels of ESR, creatinine and eosinophils and increased activities of AST, ALT, LPO and GGT were recorded in arsenic exposed subjects. Decreased levels of hemoglobin, PCV, neutrophil percentages, and GSH content and low G-6-PD activity were also observed in the arsenic exposed people. The administration of "verum" appeared to make positive modulations of these parameters, suggestive of its ameliorative potentials. Most of the subjects reported better appetite and improvement in general health, thereby indicating possibility of its use in remote arsenic-contaminated areas as an interim health support measure to a large population at risk.
数以百万计的人面临着地下水砷污染的风险,但无砷饮用水的供应严重不足。本研究旨在检验一种据报道对居住在高风险砷污染地区但饮用无砷水的人群具有改善潜力的顺势疗法强化药物,是否也能改善居住在高风险砷污染地区且饮用含砷污染水的受试者的砷中毒情况。这项初步研究是在达斯迪亚村(砷污染地区)的20名男性和19名女性身上进行的,他们最初同意充当志愿者;但多达14名受试者,其中大多数是服用安慰剂的,后来退出了。来自遥远的帕敦巴萨村(无砷地区)的18名志愿者,14名男性和4名女性,作为阴性对照。在一项双盲安慰剂对照研究中,顺势疗法的白砷30强化药物及其安慰剂(震荡酒精30)被随机给予志愿者。在给予真品或安慰剂2个月前后,分析了尿液和血液中的砷含量以及血液中几种广泛接受的毒性生物标志物和病理参数。砷暴露受试者的血沉、肌酐和嗜酸性粒细胞水平升高,谷草转氨酶、谷丙转氨酶、脂质过氧化和γ-谷氨酰转肽酶的活性增加。在砷暴露人群中还观察到血红蛋白、红细胞压积、中性粒细胞百分比和谷胱甘肽含量降低以及葡萄糖-6-磷酸脱氢酶活性低。给予“真品”似乎对这些参数产生了积极的调节作用,表明其具有改善潜力。大多数受试者报告食欲改善,总体健康状况有所改善,从而表明有可能在偏远的砷污染地区将其用作对大量高危人群的临时健康支持措施。